Literature DB >> 22435569

CNS activity of aqueous extract of root of Cissus quadrangularis Linn. (Vitaceae).

Rajesh Kumar1, Ashish Kumar Sharma, Shubhini A Saraf, Rajiv Gupta.   

Abstract

In Ayurveda, Cissus quadrangularis Linn. is used to treat anorexia, asthma, sickle cell, colds, pain, and malaria. Aqueous C. quadrangularis extract was evaluated in vivo for its antiepileptic activity by using the maximal electroshock and isonicotinic hydrazide acid models, for its analgesic activity by using the hot plate method, and for its smooth muscle relaxant activity by using the rotarod method. Adult male Swiss mice were used for this study and animals were divided into 6 animals per group. Doses of 250 mg/kg body weight and 500 mg/kg body weight protected the mice against maximal electroshock seizure, and delayed the onset time of seizures induced by isonicotinic hydrazide acid. Prominent analgesic activity was observed using the hot plate method. The paw licking time was delayed significantly. The extract also displayed prominent smooth muscle relaxant activity. The results suggest that the aqueous extracts of C. quadrangularis roots possess anticonvulsant, analgesic, and smooth muscle relaxant properties.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 22435569     DOI: 10.3109/19390210903534962

Source DB:  PubMed          Journal:  J Diet Suppl        ISSN: 1939-0211


  2 in total

1.  Insights about multi-targeting and synergistic neuromodulators in Ayurvedic herbs against epilepsy: integrated computational studies on drug-target and protein-protein interaction networks.

Authors:  Neha Choudhary; Vikram Singh
Journal:  Sci Rep       Date:  2019-07-22       Impact factor: 4.379

2.  Clinical Pilot Study of Rectal Suppository Containing Combined Extract of Cissus quadrangularis Linn. and Acmella paniculata (Wall ex. DC.) R. K. Jansen in Acute Hemorrhoids.

Authors:  Kanokporn Niwatananun; Wirat Niwatananun; Sirivipa Piyamongkol; Darunee Hongwiset; Chidchanok Ruengorn; Kiatkriangkrai Koyratkoson; Panee Sirisa-Ard; Sunee Chansakaow; Songwut Yotsawimonwat; Chalermpong Saenjum; Ampai Phrutivorapongkul; Suporn Charumanee
Journal:  Evid Based Complement Alternat Med       Date:  2021-11-02       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.